| Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trial C Koh, L Canini, H Dahari, X Zhao, SL Uprichard, V Haynes-Williams, ... The Lancet Infectious Diseases 15 (10), 1167-1174, 2015 | 285 | 2015 |
| Surgical mask to prevent influenza transmission in households: a cluster randomized trial L Canini, L Andréoletti, P Ferrari, R D'Angelo, T Blanchon, M Lemaitre, ... PloS one 5 (11), e13998, 2010 | 185 | 2010 |
| Effects of aging on influenza virus infection dynamics EA Hernandez-Vargas, E Wilk, L Canini, FR Toapanta, SC Binder, ... Journal of virology 88 (8), 4123-4131, 2014 | 133 | 2014 |
| Population modeling of influenza A/H1N1 virus kinetics and symptom dynamics L Canini, F Carrat Journal of virology 85 (6), 2764-2770, 2011 | 122 | 2011 |
| Viral kinetic modeling: state of the art L Canini, AS Perelson Journal of pharmacokinetics and pharmacodynamics 41, 431-443, 2014 | 111 | 2014 |
| HCV kinetic and modeling analyses indicate similar time to cure among sofosbuvir combination regimens with daclatasvir, simeprevir or ledipasvir H Dahari, L Canini, F Graw, SL Uprichard, ESA Araújo, G Penaranda, ... Journal of hepatology 64 (6), 1232-1239, 2016 | 73 | 2016 |
| Impact of different oseltamivir regimens on treating influenza A virus infection and resistance emergence: insights from a modelling study L Canini, JM Conway, AS Perelson, F Carrat PLoS computational biology 10 (4), e1003568, 2014 | 69 | 2014 |
| Acute hepatitis B virus infection in humanized chimeric mice has multiphasic viral kinetics Y Ishida, TL Chung, M Imamura, N Hiraga, S Sen, H Yokomichi, C Tateno, ... Hepatology 68 (2), 473-484, 2018 | 41 | 2018 |
| Distinct immune responses and virus shedding in pigs following aerosol, intra-nasal and contact infection with pandemic swine influenza A virus, A (H1N1) 09 JD Hemmink, SB Morgan, M Aramouni, H Everett, FJ Salguero, L Canini, ... Veterinary research 47, 1-15, 2016 | 41 | 2016 |
| Heterogeneous shedding of influenza by human subjects and its implications for epidemiology and control L Canini, MEJ Woolhouse, TR Maines, F Carrat Scientific reports 6 (1), 38749, 2016 | 21 | 2016 |
| HCV kinetic and modeling analyses project shorter durations to cure under combined therapy with daclatasvir and asunaprevir in chronic HCV-infected patients L Canini, M Imamura, Y Kawakami, SL Uprichard, SJ Cotler, H Dahari, ... PLoS One 12 (12), e0187409, 2017 | 20 | 2017 |
| Hepatitis C virus dynamics and cellular gene expression in uPA‐SCID chimeric mice with humanized livers during intravenous silibinin monotherapy S DebRoy, N Hiraga, M Imamura, CN Hayes, S Akamatsu, L Canini, ... Journal of viral hepatitis 23 (9), 708-717, 2016 | 20 | 2016 |
| Prenylation inhibition with lonafarnib decreases hepatitis D levels in humans C Koh, C Yurdaydin, S Cooper, D Cory, H Dahari, V Haynes-Williams, ... Hepatology 60 (4), 2014 | 20 | 2014 |
| Vaccine-mediated protection of pigs against infection with pandemic H1N1 2009 swine influenza A virus requires a close antigenic match between the vaccine antigen and challenge … HE Everett, M Aramouni, V Coward, A Ramsay, M Kelly, S Morgan, ... Vaccine 37 (17), 2288-2293, 2019 | 19 | 2019 |
| A Bayesian evolutionary model towards understanding wildlife contribution to F4-family Mycobacterium bovis transmission in the South-West of France H Duault, L Michelet, ML Boschiroli, B Durand, L Canini Veterinary research 53 (1), 28, 2022 | 18 | 2022 |
| Early HCV viral kinetics under DAAs may optimize duration of therapy in patients with compensated cirrhosis M Gambato, L Canini, S Lens, F Graw, E Perpiñan, MC Londoño, ... Liver International 39 (5), 826-834, 2019 | 16 | 2019 |
| Severity of liver disease affects HCV kinetics in patients treated with intravenous silibinin monotherapy L Canini, S DebRoy, Z Mariño, JM Conway, G Crespo, M Navasa, ... Antiviral therapy 20 (2), 149-155, 2015 | 16 | 2015 |
| Timelines of infection and transmission dynamics of H1N1pdm09 in swine L Canini, B Holzer, S Morgan, J Dinie Hemmink, B Clark, ... PLoS pathogens 16 (7), e1008628, 2020 | 13 | 2020 |
| Pharmacokinetics and pharmacodynamics modeling of lonafarnib in patients with chronic hepatitis delta virus infection L Canini, C Koh, SJ Cotler, SL Uprichard, MA Winters, MAT Han, ... Hepatology communications 1 (4), 288-292, 2017 | 12 | 2017 |
| Methods combining genomic and epidemiological data in the reconstruction of transmission trees: a systematic review H Duault, B Durand, L Canini Pathogens 11 (2), 252, 2022 | 11 | 2022 |
